TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
Completed
- Conditions
- Healthy
- Registration Number
- NCT02203981
- Lead Sponsor
- Topcon Medical Systems, Inc.
- Brief Summary
To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- No known ocular pathologies
Exclusion Criteria
- Any known ocular pathologies
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinal Thickness Day 1
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does TopQ cut-off determination improve diagnostic accuracy in retinal imaging using 3D-OCT Maestro and 3D OCT-2000?
What are the comparative performance metrics of 3D-OCT Maestro and 3D OCT-2000 in TopQ cut-off validation?
Which retinal biomarkers correlate with TopQ cut-off thresholds in healthy subjects using 3D-OCT?
How do Topcon's TopQ cut-off values compare to other OCT software in detecting subclinical retinal changes?
What technical limitations affect TopQ cut-off determination in 3D-OCT devices for ophthalmic diagnostics?
Trial Locations
- Locations (1)
Topcon Medical Systems, Inc.
🇺🇸Oakland, New Jersey, United States
Topcon Medical Systems, Inc.🇺🇸Oakland, New Jersey, United States